Cochrane Abstracts
Immunotherapy for advanced renal cell cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunotherapy for Advanced Renal Cell Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439045/all/Immunotherapy_for_advanced_renal_cell_cancer.
Immunotherapy for advanced renal cell cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439045/all/Immunotherapy_for_advanced_renal_cell_cancer. Accessed January 21, 2026.
Immunotherapy for advanced renal cell cancer. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439045/all/Immunotherapy_for_advanced_renal_cell_cancer
Immunotherapy for Advanced Renal Cell Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439045/all/Immunotherapy_for_advanced_renal_cell_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunotherapy for advanced renal cell cancer
ID - 439045
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439045/all/Immunotherapy_for_advanced_renal_cell_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
